Latest Industry Insights

The study of brain tumors using real-time imaging of the brain in live disease models is critical for elucidating disease mechanisms and developing novel treatment strategies. Such research requires full characterization of healthy and disease phenotypes using a multi-omics analysis, as described in this blog.

Technology Networks recently spoke with Stephen Williams, CMO at biotechnology company SomaLogic, to learn more about research progress in the proteomics space and the technology that has enabled it.

Speaking to Technology Networks, Ryan Denomme highlights the key challenges faced when using “traditional” surface plasmon resonance (SPR), how SPR is being used to aid drug discoveries, and explains the benefits of designing an SPR instrument that integrates digital microfluidics, artificial intelligence, and nanotechnology.

Technology Networks spoke with Jonathan Widdowson, Director of ProColl and Enterprise Fellow at the Royal Academy of Engineering Enterprise Hub, to learn more about how yeast can be used to manufacture collagens and the applications of this approach.

Over the last five to ten years, multi-modal imaging has become established as a significant component of a preclinical researcher’s analytical toolbox. Here, we highlight perhaps the most used and certainly the most sensitive and quantitative of these imaging modalities, the combination of positron emission tomography (PET) with X-ray computed tomography (CT), or PET/CT.

In this interview, Gaia Fancellu, of Iceni Diagnostics, talks about her work in more detail, discusses the challenges of studying GSDs, and highlights the advantages of using a “Systems Medicine” approach to do so.

Variability in the quality of raw materials can not only impact production yields, but can also affect the quality, efficacy and safety of the final pharmaceutical product. In this interview, learn about how the capabilities of two handheld analyzers ensure reliable material identity verification.

Many clinical trials fail due to lack of efficacy. But while some of this may be due to poor target selection during the drug discovery process, it’s becoming increasingly clear that only certain patients respond to treatments. So how exactly does precision medicine increase the likelihood of success in clinical trials?

Introduced back in March 2019, Cell Mentor^TM is an online educational resource for biology students and researchers, created by Cell Signaling Technology and Cell Press. To open the resource up to even more scientists, a Chinese version of the site was recently launched.

A typical drug compound library can easily be comprised of millions of compounds – managing, processing and analyzing these libraries takes both time and effort, as well as being costly. But what if it was possible to screen vast libraries in days, rather than weeks, or even months?